(Q26772220)

Genome sequencing identifies a basis for everolimus sensitivity

volume

17

0 references

issue

2

0 references

page(s)

12

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Modulation of mismatch repair and genomic stability by miR-155

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Cancer epigenomics: DNA methylomes and histone-modification maps

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Genomic Characterization of Upper Tract Urothelial Carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Potential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

European guidelines on upper tract urothelial carcinomas: 2013 update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Expression of p53 in upper urinary tract urothelial carcinoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Expression of parvin-β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

The COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

DNA copy number aberrations associated with lymphovascular invasion in upper urinary tract urothelial carcinoma

28 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Adhesion molecules alpha, beta and gamma-catenin as prognostic factors of tumour progression in upper urinary tract urothelial tumours: the role of AKT-P/GSK-3beta/beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Nuclear factor-κB activation predicts an unfavourable outcome in human upper urinary tract urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Microsatellite Instability in Urothelial Carcinoma of the Upper Urinary Tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-015-0566-Y

Molecular grading of tumors of the upper urothelial tract using FGFR3 mutation status identifies patients with favorable prognosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Prognostic value of p53 protein overexpression in upper tract urothelial carcinomas in Taiwan

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

CCND1 1722 polymorphism and potential relevance to upper tract urothelial cancer.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

HER-2/AKT expression in upper urinary tract urothelial carcinoma: prognostic implications.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4823991

Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival

28 November 2018

1 reference

12 December 2020

Comparative genomic hybridization analysis of transitional cell carcinomas of the renal pelvis

1 reference

12 December 2020

Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancer

1 reference

12 December 2020

Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter

1 reference

12 December 2020

EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology

1 reference

12 December 2020

Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer

1 reference

12 December 2020

DNA repair genes and prognosis in sporadic forms of urothelial carcinoma of the upper urinary tract

1 reference

12 December 2020

Glucose-regulated protein 78 expression in urothelial carcinoma of the upper urinary tract

1 reference

12 December 2020

Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma

1 reference

12 December 2020

p53 and human papillomavirus dna in renal pelvic and ureteral carcinoma including dysplastic lesions

1 reference

12 December 2020

Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter

1 reference

12 December 2020

Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia

1 reference

12 December 2020

The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter

1 reference

12 December 2020